% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, AŞ Message Board

  • dubbel_bee dubbel_bee Jul 15, 2013 9:16 PM Flag

    UBS raises target price to $150.00

    Research analysts at UBS AG hoisted their price objective on shares of Onyx Pharmaceuticals (NASDAQ: ONXX) from $110.00 to $150.00 in a report released on Monday, ARN reports. UBS AG’s price objective would indicate a potential upside of 14.36% from the stock’s previous close.

    Source: zolmax